XXXX injection into cisterna magna for relief of advanced intractable @entity5 in the faciocephalic area.

@entity1 @entity129 @entity5 @entity73 @entity653 @entity3971 @entity51 @entity158
Between 1973 and 1980 a solution of @entity3971 in @entity653 into the cisterna magna was injected in 38 @entity1 suffering from advanced intractable @entity158 due to @entity5 of faciocephalic area. Owing to the poor neurological and general condition of our @entity1 , surgical procedures were discarded. @entity1 's age ranged from 36 to 76 years and @entity158 diffusion involved many @entity129 . Follow-up studies after @entity3971 injections were carried out in 22 @entity1 : mean survival time proved to be 137 days. In 76% of cases, before neurolytic treatment, narcotics had been administered. In this series @entity158 relief seemed to be poor in 50%, good in 34% while it was unclassifiable in the remaining 16% of the cases due to an incomplete follow-up. These last @entity1 were likely to show favorable results. Complications arising immediately after @entity3971 injections are described. Long lasting disabling @entity51 were recorded in 18% of cases. Less severe complications were shown in 71% of the @entity1 . The most frequent ones were @entity73 of the trigeminal area and reversible paresis of the 7th cranial nerve. Despite the poor general conditions, no fatal outcome was seen in our @entity1 . No significant relationship between @entity158 was found. The pathophysiological mechanisms of @entity158 suppression, induced by @entity3971 injection in the faciocephalic area are discussed. The value of this simple technique is briefly assessed in comparison to other analgesic procedures.
